Detalhe da pesquisa
1.
Machine learning integrates genomic signatures for subclassification beyond primary and secondary acute myeloid leukemia.
Blood
; 138(19): 1885-1895, 2021 11 11.
Artigo
Inglês
| MEDLINE | ID: mdl-34075412
2.
Machine learning demonstrates that somatic mutations imprint invariant morphologic features in myelodysplastic syndromes.
Blood
; 136(20): 2249-2262, 2020 11 12.
Artigo
Inglês
| MEDLINE | ID: mdl-32961553
3.
Molecular landscape and clonal architecture of adult myelodysplastic/myeloproliferative neoplasms.
Blood
; 136(16): 1851-1862, 2020 10 15.
Artigo
Inglês
| MEDLINE | ID: mdl-32573691
4.
Extended experience with a non-cytotoxic DNMT1-targeting regimen of decitabine to treat myeloid malignancies.
Br J Haematol
; 188(6): 924-929, 2020 03.
Artigo
Inglês
| MEDLINE | ID: mdl-31736067
5.
Impact of germline CTC1 alterations on telomere length in acquired bone marrow failure.
Br J Haematol
; 185(5): 935-939, 2019 06.
Artigo
Inglês
| MEDLINE | ID: mdl-30891747
6.
Genomics of therapy-related myeloid neoplasms.
Haematologica
; 105(3): e98-e101, 2020 03.
Artigo
Inglês
| MEDLINE | ID: mdl-31413096
7.
Amplified EPOR/JAK2 Genes Define a Unique Subtype of Acute Erythroid Leukemia.
Blood Cancer Discov
; 3(5): 410-427, 2022 09 06.
Artigo
Inglês
| MEDLINE | ID: mdl-35839275
8.
Clinical and basic implications of dynamic T cell receptor clonotyping in hematopoietic cell transplantation.
JCI Insight
; 6(13)2021 07 08.
Artigo
Inglês
| MEDLINE | ID: mdl-34236054
9.
Somatic mutations in lymphocytes in patients with immune-mediated aplastic anemia.
Leukemia
; 35(5): 1365-1379, 2021 05.
Artigo
Inglês
| MEDLINE | ID: mdl-33785863
10.
Complex landscape of alternative splicing in myeloid neoplasms.
Leukemia
; 35(4): 1108-1120, 2021 04.
Artigo
Inglês
| MEDLINE | ID: mdl-32753690
11.
Influence of Killer Immunoglobulin-Like Receptors and Somatic Mutations on Transplant Outcomes in Acute Myeloid Leukemia.
Transplant Cell Ther
; 27(11): 917.e1-917.e9, 2021 11.
Artigo
Inglês
| MEDLINE | ID: mdl-34380091
12.
A Therapeutic Strategy for Preferential Targeting of TET2 Mutant and TET-dioxygenase Deficient Cells in Myeloid Neoplasms.
Blood Cancer Discov
; 2(2): 146-161, 2021 03.
Artigo
Inglês
| MEDLINE | ID: mdl-33681816
13.
Context dependent effects of ascorbic acid treatment in TET2 mutant myeloid neoplasia.
Commun Biol
; 3(1): 493, 2020 09 07.
Artigo
Inglês
| MEDLINE | ID: mdl-32895473
14.
Subclonal STAT3 mutations solidify clonal dominance.
Blood Adv
; 3(6): 917-921, 2019 03 26.
Artigo
Inglês
| MEDLINE | ID: mdl-30898763
15.
Genomic Biomarkers to Predict Resistance to Hypomethylating Agents in Patients With Myelodysplastic Syndromes Using Artificial Intelligence.
JCO Precis Oncol
; 32019.
Artigo
Inglês
| MEDLINE | ID: mdl-31663066
16.
Distinct clinical and biological implications of CUX1 in myeloid neoplasms.
Blood Adv
; 3(14): 2164-2178, 2019 07 23.
Artigo
Inglês
| MEDLINE | ID: mdl-31320321
17.
Invariant patterns of clonal succession determine specific clinical features of myelodysplastic syndromes.
Nat Commun
; 10(1): 5386, 2019 11 26.
Artigo
Inglês
| MEDLINE | ID: mdl-31772163
18.
Molecular characterization of the histone acetyltransferase CREBBP/EP300 genes in myeloid neoplasia.
Leukemia
; 36(4): 1185-1188, 2022 04.
Artigo
Inglês
| MEDLINE | ID: mdl-34845315
19.
Novel invariant features of Good syndrome.
Leukemia
; 35(6): 1792-1796, 2021 06.
Artigo
Inglês
| MEDLINE | ID: mdl-33414481
20.
Clonal trajectories and cellular dynamics of myeloid neoplasms with SF3B1 mutations.
Leukemia
; 35(11): 3324-3328, 2021 11.
Artigo
Inglês
| MEDLINE | ID: mdl-33603144